Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2024

Volume: 14 , Issue: 2

Indexed by

Indexed by DOAJ

Article Access statistics

Viewed: 234

Emailed: 0

PDF Downloaded: 410

Panacea Journal of Medical Sciences


Correlation of ER & PR with proto-oncogene & grades of invasive duct carcinoma


Full Text PDF Share on Facebook Share on Twitter


Original Article

Author Details : Pooja Agarwal, Dupinder Kaur*

Volume : 11, Issue : 1, Year : 2021

Article Page : 37-40

https://10.18231/j.pjms.2021.010

Article Metrics



Suggest article by email


Abstract

Background & Methods: The present study entitled “Correlation of ER & PR with proto-oncogene & grades of invasive duct carcinoma” was conducted in Dept. of Pathology, at SRMSIMS, Bareilly.
Result: The quick scoring of ER & PR is combination of proportion and intensity scoring. Out of 56 cases, 24 cases (42.85%) were ER negative & 22 cases (39.28%) were PR negative while both were negative in 18 cases (32.14%). There was a significant relationship between tumour grading & receptor status. As the grade of tumour increases ER & PR positivity decreases. Most of the tumour of grade 01 were both ER & PR positive. Here the value of (p<0> Study Designed: Observational Study
Conclusion: For all invasive carcinomas, hormone receptor status is also studied using immunoperoxidase method and Quick scoring was done. Hormone receptor status was also correlated with other tumor characteristics as histological grading. Both ER & PR positive immune staining was observed in 71.42% cases of grade I, 64.10?sesof grade II were positive for ER & 25% were positive for PR and20% cases of grade III were found positive for ER & 10% was found positive for PR.

Keywords: ER & PR, Pro-oncogene & Carcinoma.


How to cite : Agarwal P , Kaur D , Correlation of ER & PR with proto-oncogene & grades of invasive duct carcinoma. Panacea J Med Sci 2021;11(1):37-40

Copyright © 2021 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)